AHR: Holder files Form 144 to sell 20,010 shares on NYSE

Rhea-AI Filing Summary

American Healthcare REIT (AHR) filed a Form 144 notice for a proposed sale of 20,010 shares of common stock. The filing lists an aggregate market value of $994,105, to be transacted through Merrill, with the NYSE named as the exchange and an approximate sale date of 11/10/2025. Shares outstanding were 176,908,238.

The shares to be sold were acquired via restricted stock vesting on several dates, including 10/01/2023 (5,762), 06/15/2024 (3,025), 10/01/2024 (5,762), 02/09/2025 (1,851), and 11/07/2025 (3,610).

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill 8890 Lyra Drive, 5th Floor Columbus OH 43240	20010	994105	176908238	11/10/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/01/2023	Restricted Stock Vesting	American Healthcare REIT Inc			5762	10/01/2023	NA
Common	06/15/2024	Restricted Stock Vesting	American Healthcare REIT Inc			3025	06/15/2024	NA
Common	10/01/2024	Restricted Stock Vesting	American Healthcare REIT Inc			5762	10/01/2024	NA
Common	02/09/2025	Restricted Stock Vesting	American Healthcare REIT Inc			1851	02/09/2025	NA
Common	11/07/2025	Restricted Stock Vesting	American Healthcare REIT Inc			3610	11/07/2025	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did AHR file in this notice?

AHR filed a Form 144 notice indicating a proposed sale of common stock by a holder.

How many AHR shares are proposed to be sold?

The filing lists 20,010 shares of AHR common stock.

What is the aggregate market value of the proposed sale?

The filing states an aggregate market value of $994,105.

When is the approximate sale date and where will it occur?

The approximate sale date is 11/10/2025 on the NYSE.

Who is the broker named in the filing?

The broker is Merrill (8890 Lyra Drive, 5th Floor, Columbus, OH 43240).

How were the shares acquired?

They were acquired via restricted stock vesting on multiple dates, including 10/01/2023, 06/15/2024, 10/01/2024, 02/09/2025, and 11/07/2025.

How many AHR shares are outstanding?

The filing lists 176,908,238 shares outstanding.